AMAM(Delisted)
Ambrx BiopharmaยทNASDAQ
--
--(--)
What is the analyst consensus for AMAM?
- AMAM holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 0.00/10 (Neutral).
